MediXall Group
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-34.97-58.03-32.73-5.68-76.87-49.03-43.34-14.05-18.13-10.93-0.94-76.87
Price/Sales ratio
813.26N/AN/AN/A5.67K78.72K55.22KN/A7.29K1.25K-54.1178.72K
Price/Book Value ratio
-84.62-38.01-11.38-4.12-561.77269.40372.75218.32-321.69-20.34-2.22-561.77
Price/Cash Flow ratio
-108.66-819.52463.48-5.60-61.05-65.73-63.30-23.80-23.35-20.96-1.63-61.05
Price/Free Cash Flow ratio
-108.66-819.52463.48-5.60-56.17-58.35-62.88-23.19-23.28-20.95-1.63-56.17
Price/Earnings Growth ratio
-0.051.550.67-0.070.87-0.91-99.46-0.331.56-1.91-0.07-0.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%N/AN/AN/A96.23%-92010.17%-51065.21%N/A-20349.52%-5296.21%N/A-92010.17%
Operating Profit Margin
-2303.67%N/AN/AN/A-7380.62%-155.90%-127409.72%N/A-43561.26%-11035.15%5876.00%-7380.62%
Pretax Profit Margin
-2325.16%N/AN/AN/A-7380.62%-160572.06%-127409.72%N/A-41350.94%-11524.62%5737.51%-7380.62%
Net Profit Margin
-2325.16%N/AN/AN/A-7380.62%-160572.06%-127409.72%N/A-40245.78%-11524.62%5737.51%-7380.62%
Effective Tax Rate
N/AN/A100%100%N/A2.90%2.97%3.41%2.67%N/AN/A2.90%
Return on Assets
-2172.85%-180975.39%-1394.48%-571.58%-446.19%-409.40%-364.71%-360.94%-533.31%-792.37%-672.63%-409.40%
Return On Equity
241.95%65.51%34.78%72.57%730.78%-549.47%-860.05%-1553.27%1774.32%186.14%482.12%482.12%
Return on Capital Employed
239.72%65.51%34.78%72.57%730.78%-0.53%-770.42%-1135.86%6967.55%187.94%263.21%263.21%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Quick Ratio
0.100.00-0.020.110.321.940.901.010.270.000.021.94
Cash ratio
0.100.00N/A0.110.321.080.900.570.050.000.021.08
Days of Sales Outstanding
N/AN/AN/AN/A357.7531.54KN/AN/AN/AN/AN/A31.54K
Days of Inventory outstanding
N/AN/AN/AN/A-9.50N/AN/AN/AN/AN/AN/A-9.50
Operating Cycle
N/AN/AN/AN/A348.2531.54KN/AN/AN/AN/AN/A31.54K
Days of Payables Outstanding
N/AN/A970.831.93K132.98K34.9442.7182.4270.09125.55N/A34.94
Cash Conversion Cycle
N/AN/AN/AN/A-132.63K31.51K-42.71N/A-70.09-125.55N/A-132.63K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A0.070.100.062.963.85N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A0.170.43-0.20-0.69-1.35N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.26N/AN/A-0.09N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.150.30-0.25-2.29-3.59N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-32.81-21.13-67.64-1.39-1.73N/A
Company Equity Multiplier
-0.11-0.00-0.02-0.12-1.631.342.354.30-3.32-0.23-0.35-1.63
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-7.48N/AN/AN/A-92.93-1.19K-872.26N/A-312.45-60.0833.07-92.93
Free Cash Flow / Operating Cash Flow Ratio
11111.081.121.001.021.001.000.991.12
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-32.81-21.13-67.64-1.39-1.73N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-32.81-138.07-67.64-1.39-1.94N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A